Benchmark Maintains Buy on DexCom, Raises Price Target to $82

Benzinga Newsdesk www.benzinga.com Positive 73.0%

Neg 0% Neu 0% Pos 73%

Benchmark analyst Bruce D. Jackson maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $77 to $82.